Expression of matrix metalloproteinase‐2 and matrix metalloproteinase‐9 in recurrent chronic rhinosinusitis with nasal polyposis
Open Access
- 6 October 2012
- journal article
- research article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 29 (1) , 26-31
Abstract
Matrix metalloproteinase (MMP) is involved in the upper airway remodeling process. We hypothesized that MMP had an additive effect on the formation of recurrent nasal polyp. We also investigated the association between the functional promoter polymorphism of MMPs and the intensity of labeling index. Expressions of MMP-2 and MMP-9 were assessed via immunohistochemical staining and compared between different groups, including recurrent nasal polyps, nonrecurrent nasal polyps, and control nasal mucosa. Two promoter functional single-nucleotide polymorphisms (rs3918242 for MMP-9 and rs243865 for MMP-2) were selected to correlate with staining intensity. Expression of MMP-9 was significantly enhanced in gland for recurrent nasal polyp (p = 0.016) and nonrecurrent nasal polyp (p = 0.005) compared to the control. MMP-2 positivity was significantly increased in surface epithelium for recurrent nasal polyp (p = 0.004) compared to the control (p = 0.061). However, there was no significant difference in MMP-9 and MMP-2 expressions between recurrent and nonrecurrent nasal polyps. Genetic polymorphism of MMP-2 and MMP-9 functional promoters was not associated with the intensity of labeling index. These results suggested that up-regulation of MMP-9 in gland and MMP-2 in surface epithelium was characteristic of both recurrent and nonrecurrent nasal polyps. Pathogenesis of recurrent nasal polyps may involve a mechanism other than MMP.Keywords
Funding Information
- Kaohsiung Medical University
This publication has 34 references indexed in Scilit:
- Matrix metalloproteinase-9gene polymorphisms in nasal polyposisBMC Medical Genetics, 2010
- The −1562C/T MMP-9 promoter polymorphism does not predict MMP-9 expression levels or invasive capacity in saphenous vein smooth muscle cells cultured from different patientsAtherosclerosis, 2009
- Relationship between matrix metalloproteinases MMP‐2, MMP‐9, tissue inhibitor of matrix metalloproteinases‐1 and IL‐5, IL‐8 in nasal polypsAllergy, 2006
- Neutrophil‐Derived Metalloproteinase‐9 Predicts Healing Quality after Sinus SurgeryThe Laryngoscope, 2005
- Predictive and monitoring value of matrix metalloproteinase‐9 for healing quality after sinus surgeryWound Repair and Regeneration, 2004
- Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitisJournal of Allergy and Clinical Immunology, 2001
- Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammationJournal of Allergy and Clinical Immunology, 1998
- Polyp Pathogenesis-A Histopathological Study in Experimental Otitis MediaActa Oto-Laryngologica, 1995
- Origin of nasal polypsThe Laryngoscope, 1991
- Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.Journal of Clinical Investigation, 1990